Research Organizations

Clinical Trials

ctgov is a Web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. The Web site is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Information on is provided and updated by the sponsor or principal investigator of the clinical study. Studies are generally submitted to the Web site (that is, registered) when they begin, and the information on the site is updated throughout the study. In some cases, results of the study are submitted after the study ends. This Web site and database of clinical studies is commonly referred to as a "registry" and "results database."

MG Research Group


MG clinical research website is Led by Dr. Michael Benatar at the University of Miami, we are a team dedicated to clinical research in the field of myasthenia gravis. Our goal is to integrate the medical care of patients with MG with clinical research that is driven by the needs of the MG patient community and directed towards improved therapy. We collaborate with scientists and other researchers around the country on a wide variety of studies. We hope that you find the content of this website of interest and value to you. Please contact us via email or via phone for information about enrolling in trials or other clinical research studies, with questions about MG or to inquire about ways you can support our research efforts. Our mission is to work together with the MG patient community to find a cure for this disease.



MDA leads the search for treatments and therapies for myasthenia gravis (MG). The Association also provides comprehensive supports and expert clinical care for those living with MG.

In this section, you’ll find up-to-date information about myasthenia gravis, as well as many helpful resources. This information has been compiled with input from researchers, physicians and people affected by the disease.